Ying G. Li

Effects of the Proton Pump Inhibitor Lansoprazole on the Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel

David S. Small, Nagy A. Farid, Christopher D. Payne et al. · The Journal of Clinical Pharmacology · 2008 · 316 citations

Medicine, Pharmacokinetics, Pharmacology +10

Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (AWARD-11)

Juan P. Frías, Enzo Bonora, Luis Nevárez Ruiz et al. · Diabetes Care · 2021 · 190 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

The use of the VerifyNow P2Y12 point-of-care device to monitor platelet function across a range of P2Y12 inhibition levels following prasugrel and clopidogrel administration

Christopher D. Payne, Ying G. Li, John T. Brandt et al. · Thrombosis and Haemostasis · 2008 · 120 citations

Medicine, Pharmacology, Pharmacotherapy +17

Effect of Atorvastatin on the Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel in Healthy Subjects

Nagy A. Farid, David S. Small, Christopher D. Payne et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2008 · 87 citations

Medicine, Pharmacokinetics, Pharmacology +8

Population Pharmacokinetic Analyses to Evaluate the Influence of Intrinsic and Extrinsic Factors on Exposure of Prasugrel Active Metabolite in TRITON‐TIMI 38

Rebecca E. Wrishko, C. Steven Ernest, David S. Small et al. · The Journal of Clinical Pharmacology · 2009 · 83 citations

Pharmacy, Pharmacokinetics, Pharmacology +17